Search Results - "Elizalde, Patricia"

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer by Mercogliano, María Florencia, Bruni, Sofía, Elizalde, Patricia V, Schillaci, Roxana

“…Breast cancer is the most frequently diagnosed cancer and the principal cause of mortality by malignancy in women and represents a main problem for public…”
Get full text

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy by Mercogliano, María Florencia, Bruni, Sofía, Mauro, Florencia, Elizalde, Patricia Virginia, Schillaci, Roxana

“…Tumor necrosis factor alpha (TNFα) is a pleiotropic cytokine known to have contradictory roles in oncoimmunology. Indeed, TNFα has a central role in the onset…”
Get full text

Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells by Balañá, Maria Eugenia, Labriola, Leticia, Salatino, Mariana, Movsichoff, Federico, Peters, Giselle, Charreau, Eduardo H., Elizalde, Patricia V.

Get full text

Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis by Wu, Yanming, Zhang, Zhao, Cenciarini, Mauro E, Proietti, Cecilia J, Amasino, Matias, Hong, Tao, Yang, Mei, Liao, Yiji, Chiang, Huai-Chin, Kaklamani, Virginia G, Jeselsohn, Rinath, Vadlamudi, Ratna K, Huang, Tim Hui-Ming, Li, Rong, De Angelis, Carmine, Fu, Xiaoyong, Elizalde, Patricia V, Schiff, Rachel, Brown, Myles, Xu, Kexin

“…Resistance to cancer treatment can be driven by epigenetic reprogramming of specific transcriptomes in favor of the refractory phenotypes. Here we discover…”
Get full text

ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy by Elizalde, Patricia V, Cordo Russo, Rosalía I, Chervo, Maria F, Schillaci, Roxana

“…Approximately 15–20% of breast cancers (BC) show either membrane overexpression of ErbB-2 (MErbB-2), a member of the ErbBs family of receptor tyrosine kinases,…”
Get full text

Steroid hormone receptors: A South American perspective by Elizalde, Patricia V., Proietti, Cecilia J.

Get full text

TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer by Mercogliano, María F, De Martino, Mara, Venturutti, Leandro, Rivas, Martín A, Proietti, Cecilia J, Inurrigarro, Gloria, Frahm, Isabel, Allemand, Daniel H, Deza, Ernesto Gil, Ares, Sandra, Gercovich, Felipe G, Guzmán, Pablo, Roa, Juan C, Elizalde, Patricia V, Schillaci, Roxana

“…Although trastuzumab administration improved the outcome of HER2-positive breast cancer patients, resistance events hamper its clinical benefits. We…”
Get full text

Corrigendum to “Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer” [Steroids 76 (2011) 381–392] by Proietti, Cecilia J., Béguelin, Wendy, Díaz Flaqué, María Celeste, Cayrol, Florencia, Rivas, Martín A., Tkach, Mercedes, Charreau, Eduardo H., Schillaci, Roxana, Elizalde, Patricia V.

Get full text

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development by Rivas, Martin A, Venturutti, Leandro, Huang, Yi-Wen, Schillaci, Roxana, Huang, Tim Hui-Ming, Elizalde, Patricia V

“…Experimental and clinical evidence points to a critical role of progesterone and the nuclear progesterone receptor (PR) in controlling mammary gland…”
Get full text

Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions by Proietti, Cecilia J., Cenciarini, Mauro E., Elizalde, Patricia V.

“…Progesterone receptor (PR) is a master regulator in female reproductive tissues that controls developmental processes and proliferation and differentiation…”
Get full text

Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth by Izzo, Franco, Mercogliano, Florencia, Venturutti, Leandro, Tkach, Mercedes, Inurrigarro, Gloria, Schillaci, Roxana, Cerchietti, Leandro, Elizalde, Patricia V, Proietti, Cecilia J

“…The transcription factor GATA3 is involved in mammary gland development and is crucial for the maintenance of the differentiated status of luminal epithelial…”
Get full text

Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy by Flaqué, María C. Díaz, Galigniana, Natalia M, Béguelin, Wendy, Vicario, Rocío, Proietti, Cecilia J, Russo, Rosalía Cordo, Rivas, Martín A, Tkach, Mercedes, Guzmán, Pablo, Roa, Juan C, Maronna, Esteban, Pineda, Viviana, Muéoz, Sergio, Mercogliano, María Florencia, Charreau, Eduardo H, Yankilevich, Patricio, Schillaci, Roxana, Elizalde, Patricia V

Get full text

Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression by Bruni, Sofia, Mauro, Florencia L, Proietti, Cecilia J, Cordo-Russo, Rosalia I, Rivas, Martin A, Inurrigarro, Gloria, Dupont, Agustina, Rocha, Dario, Fernández, Elmer A, Deza, Ernesto Gil, Lopez Della Vecchia, Daniel, Barchuk, Sabrina, Figurelli, Silvina, Lasso, David, Friedrich, Adrián D, Santilli, María C, Regge, María V, Lebersztein, Gabriel, Levit, Claudio, Anfuso, Fabiana, Castiglione, Teresa, Elizalde, Patricia V, Mercogliano, Maria F, Schillaci, Roxana

“…BackgroundThe success of HER2-positive (HER2+) breast cancer treatment with trastuzumab, an antibody that targets HER2, relies on immune response. We…”
Get full text

Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer by Madera, Santiago, Izzo, Franco, Chervo, María F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Merin, Sharon S., De Martino, Mara, Montero, Diego, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Roldán Deamicis, Agustina, Mercogliano, María F., Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V., Cordo Russo, Rosalía I.

Get full text

Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model by Durfort, Tiphanie, Tkach, Mercedes, Meschaninova, Mariya I, Rivas, Martín A, Elizalde, Patricia V, Venyaminova, Alya G, Schillaci, Roxana, François, Jean-Christophe

“…Insulin-like growth factor I (IGF-I) and its type I receptor (IGF-IR) play significant roles in tumorigenesis and in immune response. Here, we wanted to know…”
Get full text

p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth by Tkach, Mercedes, Rosemblit, Cinthia, Rivas, Martín A, Proietti, Cecilia J, Díaz Flaqué, María Celeste, Mercogliano, María Florencia, Beguelin, Wendy, Maronna, Esteban, Guzmán, Pablo, Gercovich, Felipe G, Deza, Ernesto Gil, Elizalde, Patricia V, Schillaci, Roxana

“…Stat3 is a signaling node for multiple oncogenic pathways and is therefore frequently active in breast cancer. As experimental and clinical evidence reveals…”
Get full text

Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer by Madera, Santiago, Izzo, Franco, Chervo, María F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Merin, Sharon S., De Martino, Mara, Montero, Diego, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Roldán Deamicis, Agustina, Mercogliano, María F., Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V., Cordo Russo, Rosalía I.

“…Triple-negative breast cancer (TNBC) is clinically defined by the absence of estrogen and progesterone receptors and the lack of membrane overexpression or…”
Get full text

Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3 by Béguelin, Wendy, Díaz Flaqué, María Celeste, Proietti, Cecilia J., Cayrol, Florencia, Rivas, Martín A., Tkach, Mercedes, Rosemblit, Cinthia, Tocci, Johanna M., Charreau, Eduardo H., Schillaci, Roxana, Elizalde, Patricia V.

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Regulation of telomere homeostasis and genomic stability in cancer by N 6 -adenosine methylation (m 6 A) by Lee, Ji Hoon, Hong, Juyeong, Zhang, Zhao, de la Peña Avalos, Bárbara, Proietti, Cecilia J., Deamicis, Agustina Roldán, Guzmán G., Pablo, Lam, Hung-Ming, Garcia, Jose, Roudier, Martine P., Sisk, Anthony E., De La Rosa, Richard, Vu, Kevin, Yang, Mei, Liao, Yiji, Scheirer, Jessica, Pechacek, Douglas, Yadav, Pooja, Rao, Manjeet K., Zheng, Siyuan, Johnson-Pais, Teresa L., Leach, Robin J., Elizalde, Patricia V., Dray, Eloïse, Xu, Kexin

“…Down-regulation of HMBOX1 via METTL3-catalyzed m 6 A causes genomic instability driven by telomere dysfunction in cancer. The role of RNA methylation on N 6…”
Get full text

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer by Mercogliano, María F, Inurrigarro, Gloria, De Martino, Mara, Venturutti, Leandro, Rivas, Martín A, Cordo-Russo, Rosalía, Proietti, Cecilia J, Fernández, Elmer A, Frahm, Isabel, Barchuk, Sabrina, Allemand, Daniel H, Figurelli, Silvina, Deza, Ernesto Gil, Ares, Sandra, Gercovich, Felipe G, Cortese, Eduardo, Amasino, Matías, Guzmán, Pablo, Roa, Juan C, Elizalde, Patricia V, Schillaci, Roxana

“…Invasive micropapillary carcinoma of the breast (IMPC) is a histological tumor variant that occurs with low frequency characterized by an inside-out formation…”
Get full text